These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 16331761

  • 1. A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.
    Genovese MC, Chakravarty EF, Boyle DL, Tutuncu Z, Thorburn CM, Halilhodzic M, Kroll S, Baughman J, Stewart S, Kavanaugh A.
    J Rheumatol; 2005 Dec; 32(12):2345-50. PubMed ID: 16331761
    [Abstract] [Full Text] [Related]

  • 2. A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis.
    Dalbeth N, Yeoman S, Dockerty JL, Highton J, Robinson E, Tan PL, Herman D, McQueen FM.
    Ann Rheum Dis; 2004 Jun; 63(6):718-22. PubMed ID: 15140780
    [Abstract] [Full Text] [Related]

  • 3. Phase II randomized, placebo-controlled trial of M. vaccae-derived protein (PVAC) for the treatment of psoriasis.
    Netto EM, Takahashi D, de Fátima Paim de Oliveira M, Barbosa P, Ferraz N, Paixão A, Oyafuso LK, Bortoletto C, Matos D, Paixão M, da Silva AO, Badaro R.
    Vaccine; 2006 Jun 05; 24(23):5056-63. PubMed ID: 16621200
    [Abstract] [Full Text] [Related]

  • 4. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, Smith CD, Chalmers IM, Hong P, O'Hanlon D, Kaminska E, Markland J, Sibley J, Catoggio L, Furst DE.
    Arthritis Rheum; 2001 Jun 05; 44(6):1351-8. PubMed ID: 11407694
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 05; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.
    Arthritis Rheum; 2006 Dec 05; 54(12):3962-70. PubMed ID: 17133610
    [Abstract] [Full Text] [Related]

  • 7. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T.
    Clin Ther; 2008 Jun 05; 30(6):1102-12. PubMed ID: 18640466
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192.
    Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM, Silliman N, Streisand J, Powell J, Akesson A, Coppock J, Hoogen Fv, Herrick A, Mayes MD, Veale D, Haas J, Ledbetter S, Korn JH, Black CM, Seibold JR, Cat-192 Study Group, Scleroderma Clinical Trials Consortium.
    Arthritis Rheum; 2007 Jan 05; 56(1):323-33. PubMed ID: 17195236
    [Abstract] [Full Text] [Related]

  • 9. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP, Gilkeson GS, Pyun EH, Pisetsky DS, Smith EA, Simon LS.
    J Rheumatol; 1996 Apr 05; 23(4):654-8. PubMed ID: 8730122
    [Abstract] [Full Text] [Related]

  • 10. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A, Abou-Raya S, Helmii M.
    J Rheumatol; 2008 Sep 05; 35(9):1801-8. PubMed ID: 18709692
    [Abstract] [Full Text] [Related]

  • 11. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb 05; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 12. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, Weisman MH, Barr W, Moreland LW, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold JR.
    Arthritis Rheum; 1999 Jun 05; 42(6):1194-203. PubMed ID: 10366112
    [Abstract] [Full Text] [Related]

  • 13. Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial.
    Brothers S, Asher MI, Jaksic M, Stewart AW.
    Clin Exp Dermatol; 2009 Oct 05; 34(7):770-5. PubMed ID: 19438539
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
    Apras S, Ertenli I, Ozbalkan Z, Kiraz S, Ozturk MA, Haznedaroglu IC, Cobankara V, Pay S, Calguneri M.
    Arthritis Rheum; 2003 Aug 05; 48(8):2256-61. PubMed ID: 12905480
    [Abstract] [Full Text] [Related]

  • 15. Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study.
    Montisci R, Ruscazio M, Lai S, Vacca A, Cauli A, Passiu G, Montisci M, Meloni L, Mathieu A, Iliceto S.
    Clin Ther; 2007 Jan 05; 29(1):163-71. PubMed ID: 17379056
    [Abstract] [Full Text] [Related]

  • 16. Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center.
    Pope J, McBain D, Petrlich L, Watson S, Vanderhoek L, de Leon F, Seney S, Summers K.
    Arthritis Rheum; 2011 Nov 05; 63(11):3547-51. PubMed ID: 21769850
    [Abstract] [Full Text] [Related]

  • 17. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease.
    Arkwright PD, David TJ.
    J Allergy Clin Immunol; 2001 Mar 05; 107(3):531-4. PubMed ID: 11240956
    [Abstract] [Full Text] [Related]

  • 18. Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.
    Mayes MD, O'Donnell D, Rothfield NF, Csuka ME.
    Arthritis Rheum; 2004 Feb 05; 50(2):553-7. PubMed ID: 14872498
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis.
    Knobler RM, French LE, Kim Y, Bisaccia E, Graninger W, Nahavandi H, Strobl FJ, Keystone E, Mehlmauer M, Rook AH, Braverman I, Systemic Sclerosis Study Group.
    J Am Acad Dermatol; 2006 May 05; 54(5):793-9. PubMed ID: 16635659
    [Abstract] [Full Text] [Related]

  • 20. Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC): results of an open-label trial.
    Balagon MV, Tan PL, Prestidge R, Cellona RV, Abalos RM, Tan EV, Walsh GP, Watson JD, Walsh DS.
    Clin Exp Dermatol; 2001 May 05; 26(3):233-41. PubMed ID: 11422164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.